The study intends to investigate the personal experiences of endometrial cancer patients who take part in a separate clinical study including a specific medication intervention. The major focus will be on closely following individuals' rates of trial completion and withdrawal. The data collected from this study will help improve future outcomes for all endometrial cancer patients as well as those in under-represented demographic groups.
Study Type
OBSERVATIONAL
Enrollment
500
Power Life Sciences
San Francisco, California, United States
Number of patients who decide to enroll in an endometrial cancer clinical research
Time frame: 3 months
Rate of patients who remain in an endometrial cancer clinical trial to trial completion
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.